Pharma Lab CRO ApS
CVR 40729364 · Private limited company (ApS) · Active · Low risk
Pharma Lab CRO ApS is a Private limited company (ApS), founded on , based in Hvidovre. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 6 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -5.3m and a net result of DKK -299k. CEO: Jakob Juul Rasmussen.
Bankruptcy risk for Pharma Lab CRO ApS
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40729364
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Søbyvej 11
2650 Hvidovre - Municipality
- Hvidovre
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- REDMARK, GODKENDT REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 6 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -53.3% |
| Current ratio | 65% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 15 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 1.7m | DKK 3.4m | DKK -768k |
| Net profit | DKK -299k | DKK 117k | DKK -2.5m |
| Equity | DKK -5.3m | DKK -5.0m | DKK -5.1m |
| Total assets | DKK 10.0m | DKK 13.7m | DKK 14.9m |
| Cash | DKK 394k | DKK 478k | – |
| Short-term debt | DKK 15.3m | DKK 18.7m | – |
| Avg. employees | 1 | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 49 | ||
| 1 Jan 2024 – 31 Dec 2024 | 184 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 179 | ||
| 1 Jan 2022 – 31 Dec 2022 | 172 | ||
| 1 Jan 2021 – 31 Dec 2021 | 164 | ||
| 19 Aug 2019 – 31 Dec 2020 | 199 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jakob Juul Rasmussen | Current | |
| Owner (100%) | JaJR Holding 2 ApS | Current | |
| Owner (100%) | Jakob Juul Rasmussen | ||
| Owner (100%) | JaJR Holding ApS | ||
| Auditor | REDMARK, GODKENDT REVISIONSPARTNERSELSKAB | Current | |
| Founder | Jakob Juul Rasmussen | Current |
The CEOs' other companies
Jakob Juul Rasmussen – 19 other companies
- ArnBo 64b ApS Active
- Arnbo 62 ApS Active
- DJKL Holding ApS Active
- FJKL Holding ApS Active
- HP Properties ApS Active
- Hammerholmen 4X ApS Active
- JAJR Ejendomme 2 ApS Active
- JAJR Ejendomme ApS Active
- JaJR Holding 2 ApS Active
- JaJR Holding ApS Active
- Neo Biopharm ApS Active
- Ombytningsselskabet Pharma IT ApS Fusioneret
- Pecunia IT Consulting ApS Active
- Pharma IT ApS Active
- Pharma IT ManCo ApS Active
- ProductLife ApS Active
- ProductLife Group ApS Active
- Radyx Pharma Tech ApS Active
- SJKL Holding ApS Active
Address history (0 moves)
| Søbyvej 11, 2650 Hvidovre |
Other companies at the same address
- Kant IVS Bankrupt
- ArnBo 64b ApS Active
- Arnbo 62 ApS Active
- DJKL Holding ApS Active
- FJKL Holding ApS Active
- HP Properties ApS Active
- Hammerholmen 4X ApS Active
- JAJR Ejendomme 2 ApS Active
- JAJR Ejendomme ApS Active
- JaJR Holding 2 ApS Active
- JaJR Holding ApS Active
- Ombytningsselskabet Pharma IT ApS Fusioneret
- Pecunia IT Consulting ApS Active
- Pharma IT ManCo ApS Active
- SJKL Holding ApS Active
Similar companies in Hvidovre
- ROCHE BIO DENMARK A/S Hvidovre
Questions and answers about Pharma Lab CRO ApS
Has Pharma Lab CRO ApS gone bankrupt?
No, Pharma Lab CRO ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Pharma Lab CRO ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of Pharma Lab CRO ApS?
Jakob Juul Rasmussen is the CEO of Pharma Lab CRO ApS.
Who is the auditor of Pharma Lab CRO ApS?
Pharma Lab CRO ApS most recently used REDMARK, GODKENDT REVISIONSPARTNERSELSKAB.
When was Pharma Lab CRO ApS founded?
Pharma Lab CRO ApS was founded on 19 August 2019.
What is the equity of Pharma Lab CRO ApS?
Equity was DKK -5.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.